Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact

Allergy and Asthma Proceedings

Volumn 29, Issue 3, 2008, Pages 295-303

  Stull, Donald E ^a   Vernon, Margaret K ^a   Canonica, G Walter ^b   Crespi, Simone ^c   Sandor, David ^d  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Touro College and University System   (United States)

Author keywords

Allergic rhinitis; Congestion; Congestion quantifier; CQ7; Health related quality of life; HRQL; Longitudinal models; Minimally important difference; Monitoring tool; Patient reported outcome

Indexed keywords

ADULT; ARTICLE; FEMALE; HAY FEVER; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SICKNESS IMPACT PROFILE;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NASAL OBSTRUCTION; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 46649085005     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3119     Document Type: Article

References (33)

1. D'Alonzo GE Jr. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 102:S2-S6, 2002.
2. Law AW, Reed SD, Sundy JS, et al. Direct costs of allergic rhinitis in the United States: Estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 111:296-300, 2003.
3. Meltzer EO, Szwarcberg J, and Pill MW. Allergic rhinitis, asthma, and rhinosinusitis: Diseases of the integrated airway. J Manag Care Pharm 10:310-317, 2004.
4. Reed SD, Lee TA, and McCrory DC. The economic burden of allergic rhinitis: A critical evaluation of the literature. Pharmacoeconomics 22:345-361, 2004.
5. Blaiss MS. Allergic rhinoconjunctivitis: Burden of disease. Allergy Asthma Proc 28:393-397, 2007.
6. Leong KP, Yeak SC, Saurajen AS, et al. Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy 35:288-298, 2005.
7. Stuck BA, Czajkowski J, Hagner AE, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: A controlled clinical trial. J Allergy Clin Immunol 113:663-668, 2004.
8. Kakumanu S, Glass C, and Craig T. Poor sleep and daytime somnolence in allergic rhinitis: Significance of nasal congestion. Am J Respir Med 1:195-200, 2002.
9. Gurevich F, Glass C, Davies M, et al. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc 26:268-274, 2005.
10. American Academy of Allergy, Asthma and Immunology (AAAAI). The Allergy Report: Overview of Allergic Diseases: Diagnosis, Management, and Barriers to Care. Milwaukee, WI: American Academy of Allergy, Asthma and Immunology, 2000.
11. Reilly MC, Tanner A, and Meltzer EO. Work, classroom, and activity impairment instruments: Validation studies in allergic rhinitis. Clin Drug Invest 11:278-288, 1996.
12. HealthStar Communications, Inc., in partnership with Schulman Ronca and Bucuvalas, Inc. Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary. Florham Park, NJ: Altana Pharma US, Inc., 2006.
13. Stull DE, Roberts L, Frank L, et al. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 23:811-819, 2007.
14. Baiardini I, Braido F, Cauglia S, et al. Sleep disturbances in allergic diseases. Allergy 61:1259-1267, 2006.
15. Spector SL, Nicklas RA, Chapman JA, et al. Symptom severity assessment of allergic rhinitis: Part 1. Ann Allergy Asthma Immunol 91:105-114, 2003.
16. Jumper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30:132-140, 2000.
17. Jumper EF, Rohrbaugh T, and Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 111:484-490, 2003.
18. Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 58:289-294, 2003.
19. Stull DE, Krouse J, Meltzer EO, et al. Development and validation of the Congestion Quantifier Seven-Item Test (CQT): A screening tool for nasal congestion. Value Health 10:457-465, 2007.
20. Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the medical outcomes study sleep measure. Sleep Med 6:41-44, 2005.
21. Santanello NC, DeMuro-Mercon C, Shah SR, et al. Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis. Allergy Asthma Proc 27:231-239, 2006.
22. Duncan TE, Duncan SC, and Strycker LA. An Introduction to Latent Variable Growth Curve Modeling: Concepts, Issues, and Applications. Mahwah, NJ: Lawrence Erlbaum Associates, 2006.
23. Kline RB. Principles and Practice of Structural Equation Modeling, 2nd ed. New York: The Guilford Press, 2005.
24. Browne MW, and Cudeck RA. Alternative ways of assessing model fit. In Testing Structural Equation Models. Bollen KA, and Long JS (Eds). Newbury Park, CA: Sage, 136-162, 1993.
25. Beivik E, and Olsson UH. Adding variables to improve fit: The effect of model size on fit assessment in LISREL. In Structural Equation Modeling: Present and Future. Cudeck R, du Toit S, and Sörbom D (Eds). Lincolnwood, IL: Scientific Software International, 169-194, 2001.
26. Sloan JA, Symonds T, Vargas-Chanes D, et al. Practical guidelines for assessing the clinical significance of heath related quality of life changes within clinical trials. Drug Inf J 37:23-31, 2003.
27. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 37: 469-478, 1999.
28. Wyrwich KW, Tierney WM, and Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52:861-873, 1999.
29. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum, 1988.
30. Cox DR, and Snell EJ. The Analysis of Binary Data, 2nd ed. New York: Chapman and Hall, 1989.
31. Hosmer DW, and Lemeshow S. Applied Logistic Regression, 2nd ed. New York: John Wiley & Sons, Inc., 2000.
32. Norman GR, Sloan JA, and Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 41:582-592, 2003.
33. Shikiar R, Harding G, Leahy M, et al. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): Results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 3:36, 2005.